160 related articles for article (PubMed ID: 15205605)
1. Hypersensitivity reactions to oxaliplatin: a case report and the success of a continuous infusional desensitization schedule.
Lim KH; Huang MJ; Lin HC; Su YW; Chang YF; Lin J; Chang MC; Hsieh RK
Anticancer Drugs; 2004 Jul; 15(6):605-7. PubMed ID: 15205605
[TBL] [Abstract][Full Text] [Related]
2. Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer.
Nozawa H; Muto Y; Yamada Y
Clin Ther; 2008 Jun; 30(6):1160-5. PubMed ID: 18640472
[TBL] [Abstract][Full Text] [Related]
3. Oxaliplatin hypersensitivity: case report and successful repeat desensitization.
Edmondson DA; Gruling BJ; Urmanski AM; Wong SJ; Levy MB
Am J Ther; 2007; 14(1):116-8. PubMed ID: 17303980
[TBL] [Abstract][Full Text] [Related]
4. Hypersensitivity reactions to oxaliplatin in two asian patients.
Ng CV
Ann Pharmacother; 2005 Jun; 39(6):1114-8. PubMed ID: 15886290
[TBL] [Abstract][Full Text] [Related]
5. High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin.
Kidera Y; Satoh T; Ueda S; Okamoto W; Okamoto I; Fumita S; Yonesaka K; Hayashi H; Makimura C; Okamoto K; Kiyota H; Tsurutani J; Miyazaki M; Yoshinaga M; Fujiwara K; Yamazoe Y; Moriyama K; Tsubaki M; Chiba Y; Nishida S; Nakagawa K
Int J Clin Oncol; 2011 Jun; 16(3):244-9. PubMed ID: 21243395
[TBL] [Abstract][Full Text] [Related]
6. Successful desensitization protocol for hypersensitivity reactions caused by oxaliplatin.
Rosique-Robles D; Vicent Verge JM; Borrás-Blasco J; Giner-Marco V; Casterá E; Galan-Brotons A; Abad J
Int J Clin Pharmacol Ther; 2007 Nov; 45(11):606-10. PubMed ID: 18077926
[TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin combined to 5-fluorouracil and folinic acid: an effective therapy in patients with advanced colorectal cancer.
Gerard B; Bleiberg H; Van Daele D; Gil T; Hendlisz A; Di Leo A; Fernez B; Brienza S
Anticancer Drugs; 1998 Apr; 9(4):301-5. PubMed ID: 9635919
[TBL] [Abstract][Full Text] [Related]
8. Successful desensitization to oxaliplatin.
Mis L; Fernando NH; Hurwitz HI; Morse MA
Ann Pharmacother; 2005 May; 39(5):966-9. PubMed ID: 15784807
[TBL] [Abstract][Full Text] [Related]
9. Hypersensitivity and idiosyncratic reactions to oxaliplatin.
Thomas RR; Quinn MG; Schuler B; Grem JL
Cancer; 2003 May; 97(9):2301-7. PubMed ID: 12712487
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer.
de Gramont A; Vignoud J; Tournigand C; Louvet C; André T; Varette C; Raymond E; Moreau S; Le Bail N; Krulik M
Eur J Cancer; 1997 Feb; 33(2):214-9. PubMed ID: 9135491
[TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol.
Gammon D; Bhargava P; McCormick MJ
Oncologist; 2004; 9(5):546-9. PubMed ID: 15477639
[TBL] [Abstract][Full Text] [Related]
13. The Effects of Prolonged Infusion on Reducing Oxaliplatin Hypersensitivity Reactions.
Zhang X; Zhao Y; Zheng Y; Dong Y
J Investig Allergol Clin Immunol; 2017; 27(1):65-66. PubMed ID: 28211349
[No Abstract] [Full Text] [Related]
14. Atypical presentation of fever as hypersensitivity reaction to oxaliplatin.
Khurana A; Mitsis D; Kowlgi GN; Holle LM; Clement JM
J Oncol Pharm Pract; 2016 Apr; 22(2):319-24. PubMed ID: 25361599
[TBL] [Abstract][Full Text] [Related]
15. Acute Disseminated Intravascular Coagulation after Oxaliplatin Infusion.
Waddle M; Irvin M; Gupta E; Gibbs M; Kakar TS; Gannon NA; Arthurs JR; Fischer DL; Ailawadhi S
Chemotherapy; 2017; 62(5):295-300. PubMed ID: 28505615
[TBL] [Abstract][Full Text] [Related]
16. FDA drug approval summaries: oxaliplatin.
Ibrahim A; Hirschfeld S; Cohen MH; Griebel DJ; Williams GA; Pazdur R
Oncologist; 2004; 9(1):8-12. PubMed ID: 14755010
[TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity reaction caused by folinic acid administration: a case report and literature review.
Florit-Sureda M; Conde-Estévez D; Vidal J; Montagut C
J Chemother; 2016 Dec; 28(6):500-505. PubMed ID: 26042586
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOX.
Mori Y; Nishimura T; Kitano T; Yoshimura K; Matsumoto S; Kanai M; Hazama M; Ishiguro H; Nagayama S; Yanagihara K; Teramukai S; Chiba T; Sakai Y; Fukushima M
Oncology; 2010; 79(1-2):136-43. PubMed ID: 21150228
[TBL] [Abstract][Full Text] [Related]
19. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.
Yamada Y; Takahari D; Matsumoto H; Baba H; Nakamura M; Yoshida K; Yoshida M; Iwamoto S; Shimada K; Komatsu Y; Sasaki Y; Satoh T; Takahashi K; Mishima H; Muro K; Watanabe M; Sakata Y; Morita S; Shimada Y; Sugihara K
Lancet Oncol; 2013 Dec; 14(13):1278-86. PubMed ID: 24225157
[TBL] [Abstract][Full Text] [Related]
20. Hypersensitivity and idiosyncratic reactions to oxaliplatin.
Bhargava P; Gammon D; McCormick MJ
Cancer; 2004 Jan; 100(1):211-2. PubMed ID: 14692042
[No Abstract] [Full Text] [Related]
[Next] [New Search]
